The NHS has announced a game-changing development in cancer care, introducing a quick-acting injectable form of immunotherapy that transforms lengthy hospital visits into mere minute-long procedures. Thousands of patients will benefit from this groundbreaking treatment, which eliminates the need for time-consuming intravenous infusions that previously kept cancer sufferers tethered to hospital chairs for hours.

This innovative approach represents a significant leap forward in patient-centered care, dramatically reducing the burden on those battling cancer while easing pressure on NHS resources. Medical experts are hailing the injection as a liberating option that allows patients to reclaim valuable time with loved ones rather than spending countless hours in clinical settings, marking a new chapter in compassionate healthcare delivery.